rs199422185
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018136.5(ASPM):c.9190C>T(p.Arg3064*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,611,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018136.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- microcephaly 5, primary, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive primary microcephalyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151736Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000280 AC: 7AN: 249856 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460212Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726436 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151736Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74052 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:5
- -
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 21621). This premature translational stop signal has been observed in individual(s) with clinical features of ASPM-related conditions (PMID: 14574646, 32404165, 32677750). This variant is present in population databases (rs199422185, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Arg3064*) in the ASPM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASPM are known to be pathogenic (PMID: 19028728, 23611254). -
- -
The R3064X nonsense variant in the ASPM gene has been reported previously in association with primary autosomal recessive microcephaly (MCPH) (Bond et al., 2003). The R3064X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. -
- -
Microcephaly 5, primary, autosomal recessive Pathogenic:3Other:1
- -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.003%). Stop-gained (nonsense) is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000021621 / PMID: 14574646). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
See cases Pathogenic:1
ACMG categories: PVS1,PM2,PM3,PP4,PP5 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at